Diagnosis of Embryonic Demise

Definitive Diagnostic Criteria

• The American College of Radiology recommends that embryonic demise is definitively diagnosed on transvaginal ultrasound when an embryo measures ≥7 mm crown-rump length (CRL) without cardiac activity, or when a gestational sac has a mean sac diameter (MSD) ≥25 mm without a visible embryo 1, 2, 3
• Crown-rump length ≥7 mm without cardiac activity confirms embryonic demise with 100% certainty, according to the American College of Radiology 1, 2, 3, 4
• Mean sac diameter ≥25 mm without a visible embryo confirms anembryonic pregnancy, as stated by the American College of Radiology 1, 2, 3
• Absence of embryo with cardiac activity ≥14 days after initial visualization of a gestational sac without yolk sac is a diagnostic criterion, as recommended by the American College of Radiology 1, 2, 4
• Absence of embryo with cardiac activity ≥11 days after initial visualization of a gestational sac with yolk sac is also a diagnostic criterion, according to the American College of Radiology 1, 2, 4

Findings Suggestive But Not Diagnostic of Embryonic Demise

• Embryo <7 mm CRL without cardiac activity requires follow-up ultrasound in 7-10 days, as recommended by the American College of Radiology 1, 2, 3
• Mean sac diameter 16-24 mm without visible embryo requires follow-up, according to the American College of Radiology 1, 2, 4
• Gestational sac >8 mm without yolk sac requires follow-up, as stated by the American College of Radiology 1, 2

Critical Pitfalls to Avoid

• Never diagnose embryonic demise based on a single measurement if the CRL is <7 mm, even if cardiac activity is absent, as recommended by the American College of Radiology 1, 2, 3, 4
• Always use transvaginal ultrasound for first-trimester evaluation, not transabdominal ultrasound alone, as recommended by the American College of Radiology 1, 2, 4
• Confirm gestational age by last menstrual period to avoid dating errors, as stated by the American College of Obstetricians and Gynecologists 3, 4
• Document exact measurements with CRL measured along the longest axis of the embryo, as recommended by the American College of Radiology 4

Additional Ultrasound Findings Associated with Nonviable Pregnancy

• Embryonic bradycardia (<100 beats/min before 6.3 weeks) increases concern for pregnancy loss, according to the American College of Radiology 1
• Small gestational sac relative to embryo size increases concern for pregnancy loss, as stated by the American College of Radiology 1
• Enlarged or empty amniotic cavity increases concern for pregnancy loss, according to the American College of Radiology 1
• Abnormal yolk sac size or shape (normal yolk sac is 3-6 mm) increases concern for pregnancy loss, as recommended by the American College of Radiology 1

Terminology Recommendations

• Use "embryonic demise" or "fetal demise" rather than outdated terms, as recommended by the Society of Radiologists in Ultrasound and the American College of Obstetricians and Gynecologists 3, 4, 5

Management Implications After Diagnosis

• Once embryonic demise is confirmed, expectant management is contraindicated due to increased risks, according to the American College of Obstetricians and Gynecologists 3, 5
• Active evacuation via medical or surgical methods should be offered, as recommended by the American College of Obstetricians and Gynecologists 3
• All Rh-negative women must receive 50 μg anti-D immunoglobulin to prevent alloimmunization, as stated by the American College of Obstetricians and Gynecologists 3

Diagnostic Criteria and Management of Embryonic Demise at 8 Weeks Gestation

Diagnostic Criteria

• In women at 8 weeks gestation, the absence of fetal cardiac activity on transvaginal ultrasound confirms embryonic demise and will inevitably lead to spontaneous abortion. 6
• A crown‑rump length (CRL) ≥ 7 mm without detectable cardiac activity provides 100 % certainty of embryonic demise. This threshold is endorsed by the Society of Radiologists in Ultrasound 2024 consensus guidelines. 6
• A mean sac diameter (MSD) ≥ 25 mm with no visible embryo also confirms pregnancy loss, per the same Society of Radiologists in Ultrasound 2024 consensus. 6

Terminology

• The condition should be described as “embryonic demise” or “missed abortion” rather than outdated terms such as “blighted ovum.” 6

Management Recommendations

• Immediate active evacuation—either medical or surgical—should be offered rather than expectant management to reduce maternal morbidity. 6
• Surgical vacuum aspiration has the lowest reported complication rates (hemorrhage ≈ 9 %, infection ≈ 1 %, retained tissue ≈ 1 %). 6
• Medical management with mifepristone 200 mg plus misoprostol 800 µg achieves roughly an 80 % success rate for resolving missed abortion. 6
• Expectant management is associated with significantly higher maternal morbidity (≈ 60 % vs 33 % with active treatment), intra‑amniotic infection (≈ 38 % vs 13 %), and postpartum hemorrhage (≈ 23 % vs 11 %). 6

Preventive Measures

• All Rh‑negative patients should receive 50 µg anti‑D immunoglobulin to prevent alloimmunization, as fetomaternal hemorrhage occurs in about one‑third of spontaneous abortions. 6

Common Pitfall to Avoid

• A CRL < 7 mm without cardiac activity should not be used to diagnose embryonic demise; a repeat scan in 7–10 days is recommended to avoid misdiagnosis due to dating errors. This guidance is also from the Society of Radiologists in Ultrasound 2024 consensus. 6